Company Performance Metrics
- Louis-Philippe Noel: Founder and CEO
BioTwin develops AI-powered human virtual twin technology that transforms metabolomic, biomarker, biometric, lifestyle and longitudinal health data into dynamic digital representations of human biology. Its Bio-Signature approach uses mass spectrometry to map 30,000+ biomarker-derived metabolic signals from biological samples into high-dimensional
datasets for proprietary AI models. The platform supports preventive precision health, non-medical wellness through TwinMe, clinical research, and professional decision-support workflows where validated and authorized. BioTwin's public materials cite 1 peer-reviewed and 3 pre-published publications, 3 patents, and 6 hospital and clinic collaborations. Headquartered in Quebec City, BioTwin is expanding through a strategic partnership with Abu Dhabi Biobank and M42 to advance human virtual twin technology in the UAE. Clinical and diagnostic applications remain subject to validation, privacy controls and jurisdiction-specific authorization.